Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

24 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effects of CYP2C19*2 polymorphisms on the efficacy and safety of phenazepam in patients with anxiety disorder and comorbid alcohol use disorder.
Zastrozhin MS, Skryabin VY, Torrado M, Petrovna A, Sorokin AS, Grishina EA, Ryzhikova KA, Bedina IA, Buzik OZ, Chumakov EM, Savchenko LM, Brun EA, Sychev DA. Zastrozhin MS, et al. Among authors: savchenko lm. Pharmacogenomics. 2020 Jan;21(2):111-123. doi: 10.2217/pgs-2019-0019. Pharmacogenomics. 2020. PMID: 31957548
Effects of CYP2C19*17 polymorphisms on the efficacy and safety of bromodigyrochlorophenylbenzodiazepine in patients with anxiety disorder and comorbid alcohol use disorder.
Zastrozhin MS, Antonenko AP, Nesterenko EV, Seyfullaeva LI, Mustafina VR, Esakova AP, Grishina EA, Sorokin AS, Skryabin VY, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: savchenko lm. Drug Metab Pers Ther. 2018 Dec 19;33(4):187-194. doi: 10.1515/dmpt-2018-0019. Drug Metab Pers Ther. 2018. PMID: 30325732
Using a personalized clinical decision support system for bromdihydrochlorphenylbenzodiazepine dosing in patients with anxiety disorders based on the pharmacogenomic markers.
Zastrozhin MS, Sorokin AS, Agibalova TV, Grishina EA, Antonenko AР, Rozochkin IN, Duzhev DV, Skryabin VY, Galaktionova TE, Barna IV, Orlova AV, Aguzarov AD, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: savchenko lm. Hum Psychopharmacol. 2018 Nov;33(6):e2677. doi: 10.1002/hup.2677. Epub 2018 Oct 25. Hum Psychopharmacol. 2018. PMID: 30357930
Pharmacodynamic genetic polymorphisms affect adverse drug reactions of haloperidol in patients with alcohol-use disorder.
Zastrozhin MS, Brodyansky VM, Skryabin VY, Grishina EA, Ivashchenko DV, Ryzhikova KA, Savchenko LM, Kibitov AO, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: savchenko lm. Pharmgenomics Pers Med. 2017 Jul 7;10:209-215. doi: 10.2147/PGPM.S140700. eCollection 2017. Pharmgenomics Pers Med. 2017. PMID: 28744152 Free PMC article.
Genotyping and phenotyping of CYP2D6 and CYP3A isoenzymes in patients with alcohol use disorder: correlation with haloperidol plasma concentration.
Sychev DA, Zastrozhin MS, Miroshnichenko II, Baymeeva NV, Smirnov VV, Grishina EA, Ryzhikova KA, Mirzaev KB, Markov DD, Skryabin VY, Snalina NE, Nosikova PG, Savchenko LM, Bryun EA. Sychev DA, et al. Among authors: savchenko lm. Drug Metab Pers Ther. 2017 Sep 26;32(3):129-136. doi: 10.1515/dmpt-2017-0021. Drug Metab Pers Ther. 2017. PMID: 28787271
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.
Ivashchenko DV, Yudelevich DA, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Kachanova AA, Dorina IV, Nastovich MI, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. Ivashchenko DV, et al. Among authors: savchenko lm. Drug Metab Pers Ther. 2021 Aug 12;37(1):47-53. doi: 10.1515/dmpt-2021-0124. Drug Metab Pers Ther. 2021. PMID: 35385893
CYP2D6 phenotype and ABCB1 haplotypes are associated with antipsychotic safety in adolescents experiencing acute psychotic episodes.
Ivashchenko DV, Yudelevich DA, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Kachanova AA, Dorina IV, Nastovich MI, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. Ivashchenko DV, et al. Among authors: savchenko lm. Drug Metab Pers Ther. 2021 Aug 12. doi: 10.1515/dmdi-2021-0124. Online ahead of print. Drug Metab Pers Ther. 2021. PMID: 34388331
Pharmacogenetics of antipsychotics in adolescents with acute psychotic episode during first 14 days after admission: effectiveness and safety evaluation.
Ivashchenko DV, Khoang SZ, Makhmudova BV, Buromskaya NI, Shimanov PV, Deitch RV, Akmalova KA, Shuev GN, Dorina IV, Nastovich MI, Shagovenko EN, Grishina EA, Savchenko LM, Shevchenko YS, Sychev DA. Ivashchenko DV, et al. Among authors: savchenko lm. Drug Metab Pers Ther. 2020 Aug 24;35(4). doi: 10.1515/dmpt-2020-0102. Drug Metab Pers Ther. 2020. PMID: 32827391
CYP3A subfamily activity affects the equilibrium concentration of Phenazepam® in patients with anxiety disorders and comorbid alcohol use disorder.
Zastrozhin MS, Skryabin VY, Sorokin AS, Petukhov AE, Smirnov VV, Pankratenko EP, Grishina EA, Ryzhikova KA, Panov AS, Savchenko LM, Bryun EA, Sychev DA. Zastrozhin MS, et al. Among authors: savchenko lm. Pharmacogenomics. 2020 May;21(7):449-457. doi: 10.2217/pgs-2019-0071. Epub 2020 Apr 27. Pharmacogenomics. 2020. PMID: 32336193
24 results